Earlier diagnosis of lung cancer

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Detecting Cancer earlier in Tower Hamlets – The New Network Service Dr. Tania Anastasiadis Tower Hamlets GP Cancer Lead & GP Macmillan facilitator The.
J Thorac Dis 2013;5(S5) Estimated 10 year survival 88%, regardless of treatment Survival rate 92% if surgical resection in 1 month.
1 MT vs CT: 28 day survival Number at risk CT MT day % Surviving Monotherapy.
DEVELOPMENT AND IMPLEMENTATION OF A LUNG NODULE PROGRAM Tamra Kelly, BS RRT-NPS, Gary B. Mertens, RCP, CPFT, Jenifer Beasley, RRT, Departments of Cancer.
Joint Hospital Surgical Grand Round 19 June 2004.
Early Cancer Diagnosis in Primary Care: The evolving evidence Thomas Round GP XX Place Tower Hamlets Academic Clinical Fellow KCL
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
Achieving improved cancer outcomes- a pathway approach, engaging primary care and partners Kathy Elliott Programme Director – NHS Improving Quality (Delivery.
How to manage suspected cancer
1 Non–Small-Cell Lung Cancer Diagnosis and Staging EvaluationPurpose Physical examinationIdentify signs Chest x-rayDetermine position, size, number of.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.
CLINICAL TASKFORCE UPDATE Peter Castaldi 19 June 2007 ACHSE Executive.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
National Clinical Pathway for suspected and confirmed lung cancer:
Oesophago–Gastric Cancer Audit
Risk of stroke at 3 months6 Expected Strokes at 3 months
How clinicians use data to make an impact on clinical outcomes
Andrew Low Respiratory Consultant BRI SWAG Lung SSG 15 November 2016
Melanoma Staging an update
Oesophago–Gastric Cancer
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
Surgical Treatment in Locally Advanced Prostate Cancer
Creating the perfect text…
BREAST CANCER ONCOLOGY NAVIGATION SERVICE
Coordination (benign lesions)
The National Optimum Lung Cancer Pathway
CUP SSG May 2016 Dr Matt sephton
Jane E Scullion Respiratory Nurse Consultant
Oesophago–Gastric Cancer
RISK STRATIFICATION TOOL
Dr James Carlton, Medical Adviser
Lung Cancer Audit to patient Reference Group
National Optimal Lung Pathway
Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November
Consultant Respiratory Physician Professor of Primary Care Oncology
CT Screening for Lung Cancer: Update 2016
4 NW (in-pt) REFERRAL & TREATMENT PATHWAY Referral Enter here Sources
Six stage journey When diagnosed with a brain tumour.
Dr T P E Wells 13 July 2018 Breast SSG Bath
Lung Cancer Pathways: Interim Report
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Early Diagnosis Diagnostics Cancer Waits Survivorship South West Cancer Network 14 November 2014.
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Lung Cancer Pathway Dr Heather Harris - Consultant Radiologist
The Nuances of Staging Lung cancer Gerard A
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label,
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Volume 143, Issue 5, Pages e263S-e277S (May 2013)
4 NW (in-pt) REFERRAL & TREATMENT PATHWAY Referral Enter here Sources
Pulmonary nodules discovered on CT scan of the chest
Diabetes Action Canada Workshop 2019
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
COPD in West Essex Dr.Angus Henderson Prof.Mike Roberts
Squamous cell carcinoma pathway update
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Calderdale and Huddersfield NHS Foundation Trust
Cyst-related lung malignancies as metachronous or synchronous second primary lung cancers. a–e) Two patients with stage IV lung cancer with a large mass.
Comparison of primary end-points against guidelines
Guidelines and Standards in Lung Cancer
Presentation transcript:

Earlier diagnosis of lung cancer Dr Neal Navani MA MSc PhD FRCP Consultant Respiratory Physician, UCLH Co-clinical lead, NLCA @LungConsultant

IASLC Stage grouping for TNM 8 Earlier stage improves survival;

Millimeters matter

Olesen et al BJC 2009

Diagnosing lung cancer at earlier stage -1 Engage with primary care Promote Be Clear On Cancer campaign CXR and CT capacity Ironmonger BJC 2015

Diagnosing lung cancer at earlier stage -1 Promote Be Clear On Cancer campaign May to Late August 2017

Diagnosing lung cancer at earlier stage -2 Open access / self-referral for CXR Advertising campaign Community education 55% increase in CXRs in 2011 vs previous years (Callister et al.) Reduced emergency admissions GP direct access to CT Clinical risk assessment tools

Diagnosing lung cancer at earlier stage - 3 Dysplastic airway lesions Severe dysplasia / CIS on airway biopsy or at resection margin Autofluorescence bronchoscopy Surveillance for progression to invasive carcinoma

Diagnosing lung cancer earlier Follow available guidelines Biopsy lymph nodes vs primary Nodule clinics / BTS guideline Fewer scans National optimal lung cancer pathway

Diagnosing lung cancer earlier Lung-BOOST: 132 pts Stage I - IIIA Navani et al Lancet Resp Med 2015

Diagnosing lung cancer earlier Navani et al Lancet Resp Med 2015

Diagnosing lung cancer earlier Co-morbidity management Increase biopsy rate Increase active treatment rates Increase radical treatment rates Reduce decline in PS

Summary

@LungConsultant n.navani@ucl.ac.uk Acknowledgments UCLH Lung cancer MDT UCL Respiratory NLCA team Mat Callister, David Baldwin @LungConsultant n.navani@ucl.ac.uk